You can buy or sell OpGen and other stocks, options, ETFs, and crypto commission-free!
OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). Read More The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
52 Week High
52 Week Low
NASDAQ:OPGN - Stock Price, News, & Analysis for OpGen
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the healthcare industry worldwide. The company utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Pa...
Seeking AlphaMar 2
OpGen files for $6.5M stock offering
OpGen (NASDAQ:OPGN) has filed a preliminary prospectus for a $6.5M offering of common stock. Price, volume and terms have yet to be announced....
Guru FocusFeb 27
OpGen Inc (OPGN) Files 10-K for the Fiscal Year Ended on December 31, 2018
OpGen Inc (NASDAQ:OPGN) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.
Expected May 7, After Hours